{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:36:37Z","timestamp":1777419397239,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,19]],"date-time":"2008-11-19T00:00:00Z","timestamp":1227052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00774-008-0005-y","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T13:29:30Z","timestamp":1227014970000},"page":"76-82","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Hiroshi","family":"Kaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itoko","family":"Hisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,19]]},"reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodoriguez-Portales J, Downs RW, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shan RV, Hirsch LJ, Karpf DB, for The Alendronate Phase III Osteoporosis Treatment Study Group (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437\u20131443","journal-title":"N Engl J Med"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G, The Osteoporosis Methodology Group, The Osteoporosis Research Advisory Group (2002) Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508\u2013516","journal-title":"Endocr Rev"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/er.2001-3002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G, The Osteoporosis Methodology Group, The Osteoporosis Research Advisory Group (2002) Meta-analysis of risedronate for the treatment of postmenopausal women. Endocr Rev 23:517\u2013523","journal-title":"Endocr Rev"},{"key":"5_CR4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9343(97)00025-9","volume":"103","author":"KE Ensrud","year":"1997","unstructured":"Ensrud KE, Lipschtz RC, Cauley JA, Seeley D, Nevitt MC, Scott J, Orwoll ES, Genant HK, Cummings SR (1997) Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Am J Med 103:274\u2013280","journal-title":"Am J Med"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1359\/JBMR.050104","volume":"20","author":"MC Hochberg","year":"2005","unstructured":"Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P, Ross PD, Baran D (2005) Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 20:971\u2013976","journal-title":"J Bone Miner Res"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Parlermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial. JAMA 280:2077\u20132082","journal-title":"JAMA"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00198-004-1698-y","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Barton IP, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16:475\u2013482","journal-title":"Osteoporos Int"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00198-005-1879-3","volume":"16","author":"I Shimon","year":"2005","unstructured":"Shimon I, Eshed V, Doolman R, Sela BA, Karasik A, Vered I (2005) Alendronate for osteoporosis in men with androgen-repleted hypogonadism. Osteoporos Int 16:1591\u20131596","journal-title":"Osteoporos Int"},{"key":"5_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","volume":"22","author":"SA Jamal","year":"2007","unstructured":"Jamal SA, Bauer DC, Ensrud KE, Cauley JA, Hochberg M, Ishani A, Cummings SR (2007) Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 22:503\u2013508","journal-title":"J Bone Miner Res"},{"key":"5_CR10","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","volume":"87","author":"CR Parker","year":"2002","unstructured":"Parker CR, Blackwell PJ, Fairbairn KJ, Hosking DJ (2002) Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. J Clin Endocrinol Metab 87:4482\u20134489","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-004-0596-x","volume":"23","author":"H Nawata","year":"2005","unstructured":"Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research. J Bone Miner Metab 23:105\u2013109","journal-title":"J Bone Miner Metab"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/JBMR.051018","volume":"21","author":"DC Bauer","year":"2006","unstructured":"Bauer DC, Garnero P, Hochberg MC, Santora A, Delmas P, Ewing SK, Black DM (2006) Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res 21:292\u2013299","journal-title":"J Bone Miner Res"},{"key":"5_CR13","first-page":"76","volume":"18","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga H et al (2001) Diagnostic criteria of primary osteoporosis (2000 revision). Jpn J Bone Miner Res 18:76\u201382","journal-title":"Jpn J Bone Miner Res"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","volume":"88","author":"Q Chen","year":"2003","unstructured":"Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K (2003) Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 88:4655\u20134658","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF01880447","volume":"1","author":"P Ruegsegger","year":"1991","unstructured":"Ruegsegger P, Durand E, Dambacher MA (1991) Localization of regional forearm bone loss from high-resolution computed tomographic images. Osteoporos Int 1:76\u201380","journal-title":"Osteoporos Int"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ajcn\/51.6.1106","volume":"51","author":"RB Mazess","year":"1990","unstructured":"Mazess RB, Barden HS, Bisek JP, Hanson J (1990) Dual energy X-ray absorptiometry for total-body and regional bone mineral and soft tissue composition. Am J Clin Nutr 51:1106\u20131112","journal-title":"Am J Clin Nutr"},{"key":"5_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis. Osteoporos Int 18:427\u2013444","journal-title":"Osteoporos Int"},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1359\/jbmr.070510","volume":"22","author":"LC Hofbauer","year":"2007","unstructured":"Hofbauer LC, Brueck CC, Singh SK, Dobnig H (2007) Review: osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22:1317\u20131328","journal-title":"J Bone Miner Res"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","volume":"16","author":"II Liefde de","year":"2005","unstructured":"de Liefde II, va der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16:1713\u20131720","journal-title":"Osteoporos Int"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/jc.2006-0614","volume":"91","author":"DE Bonds","year":"2006","unstructured":"Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL (2006) Risk of fracture in women with type 2 diabetes: the Women\u2019s Health Initiative Observational Study. J Clin Endocrinol Metab 91:3404\u20133410","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","volume":"24","author":"KK Nicodemus","year":"2001","unstructured":"Nicodemus KK, Folsom AR (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24:1192\u20131197","journal-title":"Diabetes Care"},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/jbmr.5650100709","volume":"10","author":"M Inaba","year":"1995","unstructured":"Inaba M, Terada M, Koyama H, Yoshida O, Ishimura E, Kawagishi T, Okuno Y, Nishizawa Y, Otani S, Morii H (1995) Influence of high glucose on 1, 25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells. J Bone Miner Res 10:1050\u20131056","journal-title":"J Bone Miner Res"},{"key":"5_CR23","first-page":"1194","volume":"80","author":"R Bouillon","year":"1995","unstructured":"Bouillon R, Bex M, Van Herck E, Laureys J, Dooms L, Lesaffre E, Ravussin E (1995) Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80:1194\u20131202","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/en.2002-220072","volume":"144","author":"H Lu","year":"2003","unstructured":"Lu H, Kraut D, Gerstenfeld LC, Graves DT (2003) Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 144:346\u2013352","journal-title":"Endocrinology"},{"key":"5_CR25","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1210\/jc.2006-0460","volume":"91","author":"H Dobnig","year":"2006","unstructured":"Dobnig H, Piswanger-Solkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A (2006) Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 91:3355\u20133363","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00223-005-0163-z","volume":"78","author":"T Yamaguchi","year":"2006","unstructured":"Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T (2006) Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5: their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int 78:18\u201324","journal-title":"Calcif Tissue Int"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s001980170075","volume":"12","author":"D Nakaoka","year":"2001","unstructured":"Nakaoka D, Sugimoto T, Kaji H, Kanzawa M, Yano S, Yamauchi M, Sugishita T, Chihara K (2001) Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women. Osteoporos Int 12:548\u2013554","journal-title":"Osteoporos Int"},{"key":"5_CR28","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1210\/jc.2007-0757","volume":"92","author":"M Kinjo","year":"2007","unstructured":"Kinjo M, Setoguchi S, Solomon DH (2007) Bone mineral density in adults with the metabolic syndrome: analysis in a population-based US sample. J Clin Endocrinol Metab 92:4161\u20134164","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00198-007-0385-1","volume":"18","author":"D Muhlen von","year":"2007","unstructured":"von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Conner E (2007) Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int 18:1337\u20131344","journal-title":"Osteoporos Int"},{"key":"5_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1359\/JBMR.0301231","volume":"19","author":"MJ Seibel","year":"2004","unstructured":"Seibel MJ, Naganathan V, Barton I, Grauer A (2004) Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. J Bone Miner Res 19:323\u2013329","journal-title":"J Bone Miner Res"},{"key":"5_CR31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1359\/jbmr.2001.16.8.1408","volume":"16","author":"P Mezquita-Raya","year":"2001","unstructured":"Mezquita-Raya P, Munoz-Torres M, Luna JD, Luna V, Lopez-Rodriguez F, Torres-Vela E, Escobar-Jimenez F (2001) Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res 16:1408\u20131415","journal-title":"J Bone Miner Res"},{"key":"5_CR32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1359\/jbmr.040125","volume":"19","author":"JA Pasco","year":"2004","unstructured":"Pasco JA, Henry MJ, Kotowicz MA, Sanders KM, Seeman E, Pasco JR, Schneider HG, Nicholson GC (2004) Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong osteoporosis study. J Bone Miner Res 19:752\u2013758","journal-title":"J Bone Miner Res"},{"key":"5_CR33","first-page":"3086","volume":"86","author":"JC Souberbielle","year":"2001","unstructured":"Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, Baulieu EE (2001) Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 86:3086\u20133090","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1359\/JBMR.050814","volume":"20","author":"NB Watts","year":"2005","unstructured":"Watts NB, Gausens P, Barton IP, Felsenberg D (2005) Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res 20:2097\u20132104","journal-title":"J Bone Miner Res"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","volume":"87","author":"MC Hochberg","year":"2002","unstructured":"Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD (2002) Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87:1586\u20131592","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-008-0005-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0005-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:22Z","timestamp":1559110462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-008-0005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s00774-008-0005-y","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,19]]}}}